Comparison of repeated doses of ivermectin versus ivermectin plus albendazole for the treatment of onchocerciasis: A randomized, open-label, clinical trial
Clinical infectious diseases
Open Access Publication
Rights and Permissions
Linda Batsa Debrah, Ute Klarmann-Schulz, Jubin Osei-Mensah, Bettina Dubben, Kerstin Fischer, Yusif Mubarik, Nana Kwame Ayisi-Boateng, Arcangelo Ricchiuto, Rolf Fimmers, Peter Konadu, Jennifer Nadal, Barbara Gruetzmacher, Gary Weil, James W Kazura, Christopher L King, Alexander Y Debrah, Achim Hoerauf, Comparison of Repeated Doses of Ivermectin Versus Ivermectin Plus Albendazole for the Treatment of Onchocerciasis: A Randomized, Open-label, Clinical Trial, Clinical Infectious Diseases, Volume 71, Issue 4, 15 August 2020, Pages 933–943, https://doi.org/10.1093/cid/ciz889. © The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
Batsa Debrah, Linda; Fischer, Kerstin; Weil, Gary; and et al., "Comparison of repeated doses of ivermectin versus ivermectin plus albendazole for the treatment of onchocerciasis: A randomized, open-label, clinical trial." Clinical infectious diseases. 71, 4. 933 - 943. (2020).
Supplemental material is available for this article at publisher site.